Spinal Modulation raises $27.4M in Series C funding
Spinal Modulation has raised $27.4 million in a new round of funding from Johnson & Johnson Development and other investors. The company will use the money to further develop its spinal cord stimulator used to treat chronic pain.
Clinica (subscription required)
| 11/13
This story published in AdvaMed SmartBrief on 11/16/2009
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|